A Systematic Review of Research Gaps in the Evaluation and Management of Localized Renal Masses

Urology

Volumn 98, Issue , 2016, Pages 14-20

  Patel, Hiten D ^a   Iyoha, Emmanuel ^b   Pierorazio, Phillip M ^a   Sozio, Stephen M ^a,c   Johnson, Michael H ^a   Sharma, Ritu ^b   Bass, Eric B ^b   Allaf, Mohamad E ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER SPECIFIC SURVIVAL; CANCER STAGING; CANCER SURGERY; COCHRANE LIBRARY; COMPARATIVE EFFECTIVENESS; CYTOPATHOLOGY; DISEASE SEVERITY; EMBASE; FINE NEEDLE ASPIRATION BIOPSY; HUMAN; KIDNEY BIOPSY; KIDNEY CARCINOMA; KIDNEY TUMOR; MEDLINE; OUTCOME ASSESSMENT; PARTIAL NEPHRECTOMY; PATIENT CARE; PERCUTANEOUS BIOPSY; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADICAL NEPHRECTOMY; REVIEW; SYSTEMATIC REVIEW; TUMOR DIAGNOSIS; TUMOR LOCALIZATION; DISEASE MANAGEMENT; GLOBAL HEALTH; HEALTH CARE QUALITY; MEDICAL RESEARCH; MORBIDITY; MULTIMODALITY CANCER THERAPY; ORGANIZATION AND MANAGEMENT; PROCEDURES; SURVIVAL RATE; TRENDS; UROLOGY;

BIOMEDICAL RESEARCH; COMBINED MODALITY THERAPY; DISEASE MANAGEMENT; GLOBAL HEALTH; HUMANS; KIDNEY NEOPLASMS; MORBIDITY; QUALITY INDICATORS, HEALTH CARE; SURVIVAL RATE; UROLOGY;

EID: 84994519218     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2016.08.013     Document Type: Review

References (27)

1. 1 Kutikov, A., Fossett, L.K., Ramchandani, P., et al. Incidence of benign pathologic findings at partial nephrectomy for solitary renal mass presumed to be renal cell carcinoma on preoperative imaging. Urology 68 (2006), 737–740 17070344.
2. 2 Lane, B.R., Babineau, D., Kattan, M.W., et al. A preoperative prognostic nomogram for solid enhancing renal tumors 7 cm or less amenable to partial nephrectomy. J Urol 178 (2007), 429–434 17561141.
3. 3 Kane, C.J., Mallin, K., Ritchey, J., Cooperberg, M.R., Carroll, P.R., Renal cell cancer stage migration: analysis of the National Cancer Data Base. Cancer 113 (2008), 78–83 18491376.
4. 4 Klatte, T., Grubmüller, B., Waldert, M., Weibl, P., Remzi, M., Laparoscopic cryoablation versus partial nephrectomy for the treatment of small renal masses: systematic review and cumulative analysis of observational studies. Eur Urol 60 (2011), 435–443 21616582.
5. 5 Thompson, R.H., Atwell, T., Schmit, G., et al. Comparison of partial nephrectomy and percutaneous ablation for cT1 renal masses. Eur Urol 67 (2015), 252–259 25108580.
6. 6 Robinson, K.A., Saldanha, I.J., McKoy, N.A., Development of a framework to identify research gaps from systematic reviews. J Clin Epidemiol 64 (2011), 1325–1330 21937195.
7. 7 Whiting, P.F., Rutjes, A.W., Westwood, M.E., et al. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med 155 (2011), 529–536 22007046.
8. 8 Higgins, J.P.T., Green, S., (eds.) Cochrane handbook for systemic reviews of interventions Version 5.1.0. The Cochrane Collaboration, 2011 Oxford, England; Available at: http://handbook.cochrane.org Accessed November 4, 2015.
9. 9 Sterne, J.A.C., Higgins, J.P.T., Reeves, B.C., A Cochrane Risk Of Bias Assessment Tool: for Non-Randomized Studies of Interventions (ACROBATNRSI), Version 1.0.0. on behalf of the development group for ACROBATNRSI; Available at: http://www.riskofbias.info, 2014 Accessed May 1, 2016.
10. 10 Methods Guide for Effectiveness and Comparative Effectiveness Reviews. AHRQ Publication No. 10(14)-EHC063-EF. Rockville, MD: Agency for Healthcare Research and Quality; Chapters; Available at: www.effectivehealthcare.ahrq.gov, 2014 Accessed May 1, 2016.
11. 11 Pierorazio, P.M., Johnson, M.H., Patel, H.D., et al. Management of Renal Masses and Localized Renal Cancer. Comparative Effectiveness Review No. 167 (Prepared by the JHU Evidence-based Practice Center under Contract No. 290-2012-00007-I.) AHRQ Publication No. 16-EHC001-EF. Rockville, MD: Agency for Healthcare Research and Quality; Available at: https://www.effectivehealthcare.ahrq.gov/search-for-guides-reviews-and-reports/?pageaction=displayproduct&productID=2186, 2016 Accessed May 1, 2016.
12. 12 Ball, M.W., Gorin, M.A., Bhayani, S.B., et al. Preoperative predictors of malignancy and unfavorable pathology for clinical T1a tumors treated with partial nephrectomy: a multi-institutional analysis. Urol Oncol Semin Orig Invest, 33, 2015, 112 e9-112.e14.
13. 13 Kutikov, A., Smaldone, M.C., Egleston, B.L., et al. Anatomic features of enhancing renal masses predict malignant and high-grade pathology: a preoperative nomogram using the RENAL Nephrometry score. Eur Urol 60 (2011), 241–248 21458155.
14. 14 Koo, K.C., Yoo, H., Shin, T.Y., et al. External validation of the RENAL nephrometry score nomogram for predicting high-grade renal cell carcinoma in solid, enhancing, and small renal masses. World J Urol 32 (2014), 249–255 24013182.
15. 15 Morrissey, J.J., Mobley, J., Figenshau, R.S., et al. Urine aquaporin 1 and perilipin 2 differentiate renal carcinomas from other imaged renal masses and bladder and prostate cancer. Mayo Clin Proc 90 (2015), 35–42 25572193.
16. 16 Gorin, M.A., Rowe, S.P., Baras, A.S., et al. Prospective evaluation of 99mTc-sestamibi SPECT/CT for the diagnosis of renal oncocytomas and hybrid oncocytic/chromophobe tumors. Eur Urol 69 (2016), 413–416 26386607.
17. 17 Patel, H.D., Johnson, M.H., Pierorazio, P.M., et al. Diagnostic accuracy and risks of biopsy in the diagnosis of a renal mass suspicious for localized renal cell carcinoma: systematic review of the literature. J Urol 195 (2016), 1340–1347 26901507.
18. 18 Patel, H.D., Pierorazio, P.M., Small renal mass—to biopsy or not? The role of biopsy in evaluation. EU Focus 2 (2016), 154–155, 10.1016/j.euf.2015.09.008.
19. 19 Rodger, M., Ramsay, T., Fergusson, D., Diagnostic randomized controlled trials: the final frontier. Trials, 13, 2012, 137 22897974.
20. 20 Van Poppel, H., Da Pozzo, L., Albrecht, W., et al. A prospective, randomised EORTC intergroup phase 3 study comparing the oncologic outcome of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma. Eur Urol 59 (2011), 543–552 21186077.
21. 21 Pierorazio, P.M., Johnson, M.H., Patel, H.D., et al. Management of renal masses and localized renal cancer: systematic review and meta-analysis. J Urol, 2016, 10.1016/j.juro.2016.04.081 in press.
22. 22 Pierorazio, P.M., Johnson, M.H., Ball, M.W., et al. Five-year analysis of a multi-institutional prospective clinical trial of delayed intervention and surveillance for small renal masses: the DISSRM Registry. Eur Urol 68 (2015), 408–415 25698065.
23. 23 Patel, H.D., Riffon, M.F., Joice, G.A., et al. A prospective, comparative study of quality of life among patients with small renal masses choosing active surveillance and primary intervention. J Urol, 2016 Epub ahead of print 27140071.
24. 24 Shuch, B., Hanley, J., Lai, J., et al. Overall survival advantage with partial nephrectomy: a bias of observational data?. Cancer 119 (2013), 2981–2989 23674264.
25. 25 Patel, H.D., Kates, M., Pierorazio, P.M., et al. Survival after diagnosis of localized T1a kidney cancer: current population-based practice of surgery and nonsurgical management. Urology 83 (2014), 126–132 24246317.
26. 26 Woldu, S.L., Weinberg, A.C., Korets, R., et al. Who really benefits from nephron-sparing surgery?. Urology 84 (2014), 860–867 25260447.
27. 27 Patel, H.D., Kates, M., Pierorazio, P.M., et al. Comorbidities and causes of death in the management of localized T1a kidney cancer. Int J Urol 21 (2014), 1086–1092 24931430.